BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 27409807)

  • 1. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence.
    Ibiza S; García-Cassani B; Ribeiro H; Carvalho T; Almeida L; Marques R; Misic AM; Bartow-McKenney C; Larson DM; Pavan WJ; Eberl G; Grice EA; Veiga-Fernandes H
    Nature; 2016 Jul; 535(7612):440-443. PubMed ID: 27409807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity.
    Chun E; Lavoie S; Fonseca-Pereira D; Bae S; Michaud M; Hoveyda HR; Fraser GL; Gallini Comeau CA; Glickman JN; Fuller MH; Layden BT; Garrett WS
    Immunity; 2019 Nov; 51(5):871-884.e6. PubMed ID: 31628054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-entrained and brain-tuned circadian circuits regulate ILC3s and gut homeostasis.
    Godinho-Silva C; Domingues RG; Rendas M; Raposo B; Ribeiro H; da Silva JA; Vieira A; Costa RM; Barbosa-Morais NL; Carvalho T; Veiga-Fernandes H
    Nature; 2019 Oct; 574(7777):254-258. PubMed ID: 31534216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ILC3s and the Willow Tree of Voices.
    Bogunovic M
    Immunity; 2016 Aug; 45(2):238-9. PubMed ID: 27533011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1 regulates ILC3-driven intestinal immunity and homeostasis.
    Jacquelot N; Xiong L; Cao WHJ; Huang Q; Yu H; Sayad A; Anttila CJA; Baldwin TM; Hickey PF; Amann-Zalcenstein D; Ohashi PS; Nutt SL; Belz GT; Seillet C
    Mucosal Immunol; 2024 Jun; 17(3):371-386. PubMed ID: 38492744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feeding-dependent VIP neuron-ILC3 circuit regulates the intestinal barrier.
    Talbot J; Hahn P; Kroehling L; Nguyen H; Li D; Littman DR
    Nature; 2020 Mar; 579(7800):575-580. PubMed ID: 32050257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulatory Sensory Circuits in Group 3 Innate Lymphoid Cell (ILC3) Function and Tissue Homeostasis.
    Domingues RG; Hepworth MR
    Front Immunol; 2020; 11():116. PubMed ID: 32117267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.
    Stojanović I; Saksida T; Miljković Đ; Pejnović N
    Front Immunol; 2021; 12():653560. PubMed ID: 34149694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms.
    Castleman MJ; Dillon SM; Purba CM; Cogswell AC; Kibbie JJ; McCarter MD; Santiago ML; Barker E; Wilson CC
    Front Immunol; 2019; 10():649. PubMed ID: 30984202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group 3 innate lymphoid cells: A trained Gutkeeper.
    Serafini N; Di Santo JP
    Immunol Rev; 2024 May; 323(1):126-137. PubMed ID: 38491842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementarity and redundancy of IL-22-producing innate lymphoid cells.
    Rankin LC; Girard-Madoux MJ; Seillet C; Mielke LA; Kerdiles Y; Fenis A; Wieduwild E; Putoczki T; Mondot S; Lantz O; Demon D; Papenfuss AT; Smyth GK; Lamkanfi M; Carotta S; Renauld JC; Shi W; Carpentier S; Soos T; Arendt C; Ugolini S; Huntington ND; Belz GT; Vivier E
    Nat Immunol; 2016 Feb; 17(2):179-86. PubMed ID: 26595889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2.
    Zhou L; Chu C; Teng F; Bessman NJ; Goc J; Santosa EK; Putzel GG; Kabata H; Kelsen JR; Baldassano RN; Shah MA; Sockolow RE; Vivier E; Eberl G; Smith KA; Sonnenberg GF
    Nature; 2019 Apr; 568(7752):405-409. PubMed ID: 30944470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCR
    Mikami Y; Scarno G; Zitti B; Shih HY; Kanno Y; Santoni A; O'Shea JJ; Sciumè G
    Eur J Immunol; 2018 Jul; 48(7):1174-1180. PubMed ID: 29524223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism.
    Mao K; Baptista AP; Tamoutounour S; Zhuang L; Bouladoux N; Martins AJ; Huang Y; Gerner MY; Belkaid Y; Germain RN
    Nature; 2018 Feb; 554(7691):255-259. PubMed ID: 29364878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of IL-12p40 and type 1 immunity by Toxoplasma gondii in the absence of the TLR-MyD88 signaling cascade.
    Snyder LM; Doherty CM; Mercer HL; Denkers EY
    PLoS Pathog; 2021 Oct; 17(10):e1009970. PubMed ID: 34597344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate lymphoid cell type 3-derived interleukin-22 boosts lipocalin-2 production in intestinal epithelial cells via synergy between STAT3 and NF-κB.
    Coorens M; Rao A; Gräfe SK; Unelius D; Lindforss U; Agerberth B; Mjösberg J; Bergman P
    J Biol Chem; 2019 Apr; 294(15):6027-6041. PubMed ID: 30782844
    [No Abstract]   [Full Text] [Related]  

  • 17. CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation.
    Ahmed A; Joseph AM; Zhou J; Horn V; Uddin J; Lyu M; Goc J; ; Sockolow RE; Wing JB; Vivier E; Sakaguchi S; Sonnenberg GF
    Nature; 2024 Jun; 630(8018):976-983. PubMed ID: 38867048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis.
    Ciccia F; Guggino G; Rizzo A; Saieva L; Peralta S; Giardina A; Cannizzaro A; Sireci G; De Leo G; Alessandro R; Triolo G
    Ann Rheum Dis; 2015 Sep; 74(9):1739-47. PubMed ID: 25902790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 3 innate lymphoid cell: a new player in liver fibrosis progression.
    Wang S; Li J; Wu S; Cheng L; Shen Y; Ma W; She W; Yang C; Wang J; Jiang W
    Clin Sci (Lond); 2018 Dec; 132(24):2565-2582. PubMed ID: 30459204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Card9-dependent IL-1β regulates IL-22 production from group 3 innate lymphoid cells and promotes colitis-associated cancer.
    Bergmann H; Roth S; Pechloff K; Kiss EA; Kuhn S; Heikenwälder M; Diefenbach A; Greten FR; Ruland J
    Eur J Immunol; 2017 Aug; 47(8):1342-1353. PubMed ID: 28586167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.